Full-Time

Sr Associate Software Engineer

Small Molecule Discovery

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior

Hyderabad, Telangana, India

In Person

Category
Full-Stack Engineering
Software Engineering
Required Skills
Python
JavaScript
React.js
SQL
Java
Postgres
Oracle
Databricks
Requirements
  • Master’s degree and 1 to 3 years of Computer Science, IT, Computational Chemistry/ Cheminformatics, Chemical Engineering or related field OR
  • Bachelor’s degree and 3 to 5 years of Computer Science, IT, Computational Chemistry/ Cheminformatics, Chemical Engineering or related field OR
  • Diploma and 7 to 9 years of Computer Science, IT, Computational Chemistry/ Cheminformatics, Chemical Engineering or related field.
  • Proficient in a General Purpose High Level Languages (e.g. Python, Java, C#.NET)
  • Proficient in a Javascript UI Framework (e.g. React, ExtJs)
  • Proficient with SQL (e.g. Oracle, PostGres, Databricks)
Responsibilities
  • Take ownership of complex software projects from conception to deployment
  • Manage software delivery scope, risk, and timeline
  • Possesses strong rapid prototyping skills and can quickly translate concepts into working code
  • Contribute to both front-end and back-end development using cloud technology
  • Develop innovative solution using generative AI technologies
  • Conduct code reviews to ensure code quality and consistency to standard methodologies
  • Create and maintain documentation on software architecture, design, deployment, disaster recovery, and operations
  • Identify and resolve technical challenges effectively
  • Stay updated with the latest trends and advancements
  • Work closely with product team, business team including scientists, and other collaborators
  • Design, develop, and implement applications and modules, including custom reports, interfaces, and enhancements
  • Analyze and understand the functional and technical requirements of applications, solutions and systems and translate them into software architecture and design specifications
  • Develop and implement unit tests, integration tests, and other testing strategies to ensure the quality of the software
  • Identify and resolve software bugs and performance issues
  • Work closely with multi-functional teams, including product management, design, and QA, to deliver high-quality software on time
  • Maintain detailed documentation of software designs, code, and development processes
  • Customize modules to meet specific business requirements
  • Work on integrating with other systems and platforms to ensure seamless data flow and functionality
  • Provide ongoing support and maintenance for applications, ensuring that they operate smoothly and efficiently
Desired Qualifications
  • 3+ years of experience in implementing and supporting biopharma scientific software platforms
  • Strong understanding of software development methodologies, mainly Agile and Scrum
  • Hands-on experience with Full Stack software development
  • Strong understanding of cloud platforms (e.g AWS) and containerization technologies (e.g., Docker, Kubernetes)
  • Working experience with DevOps practices and CI/CD pipelines
  • Experience with big data technologies (e.g., Spark, Databricks)
  • Experience with API integration, serverless, microservices architecture (e.g. Mulesoft, AWS Kafka)
  • Experience with monitoring and logging tools (e.g., Prometheus, Grafana, Splunk)
  • Experience of infrastructure as code (IaC) tools (Terraform, CloudFormation)
  • Experience with version control systems like Git
  • Experience with automated testing tools and frameworks
  • Experience with chemistry-focused software platforms (e.g., Revvity Signals Notebook, ACD/Labs, ChemAxon, Schrödinger LiveDesign/PyMOL/Maestro, BIOVIA Pipeline Pilot), compound registration systems, and AI tools for drug design.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.